The success percentage is often the first number patients ask for. There is no established success rate you can apply to your own disc. Intradiscal stem cell therapy, in which cells are injected into a spinal disc, remains investigational. Small studies may report improvements in pain or function, but they use different cells, patient groups and definitions of success. They do not establish that an injection reliably rebuilds a disc or prevents surgery.
If you are considering treatment abroad, more useful numbers appear on your scan, symptom scores and proposed treatment plan. They help you test whether an overseas offer fits your diagnosis, what recovery might involve and who will look after you once you return home.
Pfirrmann grades describe disc appearance on MRI, not your pain or automatic eligibility.
A pain score gives you and your doctors a baseline for judging change.
No clinic can promise disc regrowth, lasting pain relief or avoidance of surgery.
Grades 1–5: What your disc scan can—and cannot—tell an overseas clinic
Degenerative disc disease describes wear-related changes in the cushions between spinal bones. It can involve lumbar or cervical disc degeneration, age-related disc dehydration, annular fissures or tears in a disc’s outer ring, contained bulges, and some contained herniations. These findings may accompany chronic disc-related back or neck pain, including pain that persists despite conservative treatment. They can also appear on scans of people with little or no pain.
An MRI report may give a Pfirrmann grade from 1 to 5. Lower grades describe discs that retain more of their normal structure. Higher grades indicate more pronounced degeneration and loss of disc height. A clinic may investigate mild-to-moderate changes for an intradiscal injection, but there is no universally accepted grade that proves you are a suitable candidate. Grade alone does not identify which structure causes your pain.
Before you book abroad, send the clinic the MRI images as well as the written report. A spine specialist should match them with your symptoms and examination. Ask which specific disc level they propose to treat and what evidence links that disc to your pain. A preliminary opinion from records is useful for screening, but final medical clearance requires an in-person assessment.
Two people can have the same MRI grade and different symptoms. Studies also differ in how they select patients, prepare cells and measure improvement. Treat a precise eligibility cutoff or success claim as a question to investigate, not a promise.
Two scores—and several exclusions—shape the decision to travel
A 0–10 pain scale records how severe your pain feels. Some clinics also use the Oswestry Disability Index, scored from 0–100, to measure how much lower-back pain limits daily activities. Neither score diagnoses a painful disc. Together with imaging and examination, they establish a baseline that your overseas clinic and doctor at home can use during follow-up.
The possible candidate is usually an adult with persistent, imaging-confirmed, mild-to-moderate disc degeneration whose symptoms remain troublesome after physiotherapy, activity changes, medication or other appropriate care. A clinic should also consider whether a different source, such as a facet joint or nerve, better explains the pain.
Several findings can change or rule out the plan:
- Advanced structural disease: Severe disc collapse, marked spinal instability or major nerve compression may call for a different evaluation or procedure.
- Urgent neurological symptoms: Progressive weakness, new bladder or bowel problems, or numbness around the groin need prompt local medical assessment, not travel for an elective injection.
- Other medical concerns: Active infection, cancer or a condition that makes an injection unsafe requires individual review.
- Healing and procedure risks: Diabetes control, smoking, higher BMI, blood-thinning medicines and frailty matter more than a birthday alone. There is no single blood sugar, BMI or age threshold that makes every patient eligible or ineligible.
Send relevant health records ahead of time rather than relying on a questionnaire alone. The treating team should explain any additional tests it needs and who makes the final decision if your in-person findings differ from the remote assessment.
Four procedure stages: Where cells, imaging and consent fit
“Stem cell therapy” does not describe one standardized disc procedure. Clinics may discuss cells obtained from your own bone marrow or other tissue, or a donor-derived product. Some preparations are processed at the point of care, while others involve laboratory handling. The cell source, processing, legal status and evidence can differ substantially. A product brand or trademark does not establish effectiveness for degenerative discs.
Ask the overseas specialist to put these four stages in your written plan:
- Confirm the target. The specialist reviews your MRI, symptoms, examination and alternatives. You discuss the investigational nature of treatment and give informed consent.
- Obtain or identify the cells. Depending on the protocol, tissue may be collected from you or a donor product may be prepared. The clinic should identify the source, processor and applicable quality controls.
- Access the disc. A clinician uses image guidance to place a needle through the skin into the selected disc. The plan should identify the level treated, the imaging method and the type of anesthesia or sedation.
- Inject and observe. The prepared material is delivered according to the clinic’s protocol. The team monitors you afterward and provides activity restrictions, warning signs and follow-up instructions.
Ask exactly what will be injected: cells alone or cells combined with another material. Request the product name, manufacturer where applicable, cell source, processing method and any claims about dose or cell viability in writing. If a clinic proposes several injections or other procedures, each should have its own rationale, risks and cost.
Five report terms worth recognizing
Intradiscal: Inside the disc, rather than around a spinal nerve or joint.
Annular fissure: A split in the disc’s outer ring. It does not, by itself, prove the source of pain.
Contained herniation: Disc material protrudes but remains within its outer boundary.
Disc height: The space occupied by a disc between two spinal bones.
Fluoroscopy: Moving X-ray images used to help guide needle placement.
Three paths to compare before paying for an injection
An overseas intradiscal injection should be compared with care you could receive at home, not just with another clinic’s offer. This matters because the evidence and follow-up demands differ between options.
| Path | What it addresses | Key question abroad |
|---|---|---|
| Conservative care | Function and symptoms through guided exercise, activity changes and appropriate medication | Has an adequate, diagnosis-specific program already been tried? |
| Intradiscal cell injection | Investigational attempt to improve symptoms in selected patients | What exactly is injected, under what oversight, and who follows the result? |
| Other spine procedures | A specific cause, such as nerve compression or instability, when clinically indicated | Would treating that cause be more appropriate than injecting the disc? |
Ask a local spine specialist whether further rehabilitation, a different injection, or surgical assessment makes more sense for your findings. Receiving an investigational treatment abroad may offer access to a particular protocol, but travel can make rehabilitation and complication care harder to coordinate. If a comparable procedure is available at home, compare its oversight and continuity of care as well as its technique.
No reliable complication or success percentage: How to read clinic claims
Published experience with intradiscal cell procedures is too varied to give you a dependable complication-rate range or success-rate range for a particular clinic and product. Small studies can miss uncommon harms. An advertised percentage may also count a modest pain-score change as “success” without showing whether patients regained function or benefited long term. Ask for the study or audited clinic data behind any number and check whether its patients and procedure resemble yours.
Risks to discuss before consenting include:
- Disc infection: Often called discitis, this can require urgent assessment, imaging and prolonged treatment.
- Needle or injection injury: Bleeding, nerve irritation, worsening pain or damage to disc structures can occur.
- Product-related uncertainty: Contamination, an inflammatory reaction or other effects may depend on how a product is sourced and handled.
- No meaningful benefit: Pain may persist even when needle placement and recovery appear uncomplicated.
Ask how the team prevents infection, verifies placement, monitors adverse events and arranges urgent spine care if needed. Also ask who pays for assessment or treatment of a complication. An overseas clinic can review records and advise remotely, but it cannot replace an examination, imaging or emergency treatment near your home.
The outcome numbers need a definition
Some research follows pain and disability scores over months, sometimes with later assessments. A lower pain score can be meaningful, but it is not proof of disc regeneration. The duration of benefit varies, and there is no established number of years an injection lasts or a standard schedule for repeating it. Before booking, ask what improvement the clinician considers realistic for your symptoms and when a lack of improvement should trigger reassessment.
Two clearances: Prepare at home, then confirm the plan in person
The first clearance is remote and preliminary. Send recent MRI images and reports, prior spine imaging, specialist notes, a description of your symptoms, treatments already tried, medication and allergy lists, and relevant medical history. Include information about diabetes, smoking, previous spine procedures, infection, cancer and any new weakness or changes in sensation. The clinic can then say whether further evaluation seems worthwhile.
The second clearance happens in person, after the treating specialist examines you and reviews whether the proposed disc is still the right target. Ask what happens to your booking and deposit if that examination changes the recommendation. Arrange a local doctor who is willing to receive the discharge plan. Do not stop or change prescribed medication without instructions from the doctors responsible for your care.
Regulatory status deserves the same attention as your MRI. Ask whether the specific cell product and its proposed use are authorized in the destination, offered within an approved clinical study, or marketed as a private investigational service. Permission to operate a clinic is not the same as evidence that its disc treatment works.
Three recovery phases: What happens near the clinic and back home
Recovery instructions vary with tissue collection, sedation, the number of discs treated and your general health. Walking may resume soon after an uncomplicated needle procedure, but that does not mean the disc has healed or that normal lifting and exercise are immediately appropriate. Obtain your own written restrictions.
Immediately after injection → near the treating team. Staff monitor pain, movement and any immediate reaction. They confirm that you can move safely and understand the discharge instructions.
Early recovery → usually still close enough for review. Soreness may settle while the clinic checks for unexpected pain or signs of infection. Your required observation and travel arrangements depend on the procedure and examination findings.
Weeks to months → usually coordinated back home. You follow the agreed activity or rehabilitation plan and report changes in pain and function. Improvements, if any, may emerge gradually rather than on the day of injection.
Do not set departure based only on a package itinerary. Ask the treating doctor what examination must happen before you leave, what symptoms would delay travel, and whether sitting, carrying luggage or managing transfers will be difficult. A companion may help if sedation, discomfort or limited mobility affects you.
One written quote and one named follow-up plan
There is no single reliable international price for “stem cell therapy for degenerative discs.” Quotes can describe different cell sources, processing methods, numbers of treated levels, imaging, anesthesia and facility services. Your treatment quote is also different from the total cost of travelling and recovering away from home. A PlacidWay patient coordinator can help you obtain destination, price and travel-planning information for the options you are comparing.
Request the final inclusions and exclusions in writing. Check consultations, MRI review and new tests, tissue collection or cell-product fees, the treating clinician’s fee, imaging guidance, anesthesia, facility charges, medicines and any planned rehabilitation. Ask separately about accommodation, transfers, additional visits, treatment of complications and follow-up after you return home. A low headline quote can become a poor comparison if essential care is excluded.
Compare destinations for reasons specific to this procedure: how cell products are regulated, whether a relevant clinical study is available, how the disc specialist and laboratory work together, and whether you can access rehabilitation and urgent spine assessment if needed. Compare providers on the same written clinical details, not price alone. A credible offer names the treating provider, target disc, cell source, procedure, clinical rationale, major risks, expected recovery, total quoted inclusions and follow-up responsibility.
These questions expose gaps before you pay a deposit:
- Diagnosis: Which disc is causing my symptoms, and what findings could change that conclusion?
- People and product: Who places the needle, what spine training and intradiscal experience do they have, and who sources and processes the cells?
- Facility: What licenses, image-guidance equipment, infection controls and emergency spine-care arrangements are available?
- Evidence: What outcomes and complications have you recorded for this exact protocol, and how do you define improvement?
- Continuity: Who reviews me before departure, who answers concerns from home, and who coordinates care if the injection does not help?
Vague guarantees, unexplained percentages or a quote that does not identify the injected material need clarification. The cheapest plan is not automatically the best match for your disc or your ability to obtain care afterward.
Before departure: Two teams need the same records
Before leaving the destination, obtain a discharge summary and procedure report showing the disc level treated, cell source and product details, material injected, image-guidance method and any complications. Take relevant images, prescriptions, activity and rehabilitation instructions, emergency contacts, and a written follow-up schedule. Give copies to your doctor at home. If you received a traceable product, ask for its identifying information.
Agree in advance which clinician responds to routine questions and which local service can assess a problem promptly. Fever, escalating back or neck pain, new weakness, new numbness, or bladder or bowel changes need urgent local assessment. Contacting the overseas clinic can help share procedure details, but it must not delay emergency care.
Long-term care is more than waiting for a scan to look different. Your local team may track pain, function, strength and your return to normal activities while the overseas specialist reviews planned updates. If symptoms persist or recur, a spine specialist should reassess the diagnosis and standard treatment options. Another injection is not an automatic “maintenance” treatment. A revision procedure, if appropriate, may require care at home or another trip, so establish who would assess and arrange it before travelling.
Compare your disc treatment plan with a patient coordinator
If you are weighing intradiscal stem cell therapy abroad, ask for a plan that identifies your target disc, the exact product or cell preparation, the treating specialist and the follow-up arrangements. A PlacidWay patient coordinator can help you gather comparable proposals and questions for the clinical teams.
Request information about disc treatment abroad
References
- U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products, Including Stem Cells and Exosomes
- U.S. Food and Drug Administration — Important Patient and Consumer Information About Regenerative Medicine Therapies
- International Society for Stem Cell Research — A Closer Look at Stem Cells: Patient Resources
- ClinicalTrials.gov — Clinical Study Search
- NHS — Back Pain
- NHS — Slipped Disc
This page is for general information and is not medical advice. Consult a qualified doctor about your diagnosis, treatment options and fitness to travel.
Who stands behind this article
Health content should never be anonymous. Here are the people who wrote and checked it, with credentials you can verify independently.
Usama
As the Editor of Global Stem Cell Therapy, I provide trusted, research-based information on stem cell treatments worldwide. With over a decade of experience in medical tourism, I guide patients toward safe, effective, and affordable therapies.
This author specializes in global healthcare trends and medical education. By focusing on evidence-based practices and a patient-first approach, they provide accessible resources to help readers understand their international treatment options with clarity.
Stem Cell Therapy, Longevity & Regenerative Medicine Specialist
Dr. Alejandro Fernando is a Mexico City-based physician and medical content reviewer focused on stem cell therapy, regenerative medicine, cellular therapy and longevity medicine. His reviewer profile lists medical and postgraduate training related to regenerative medicine, cellular therapy and stem cell biology.
How this article was checked
